China's medical robots take on foreign rivals

 13-Feb-17, CCTV 

Developed by Beijing Tinavi Medical Technology Co with the help of Jishuitan Hospital, Phecda is part of the broad effort by Chinese companies to outcompete foreign rivals just as the country's use of medical robots is set to take off, thanks in part to an aging population.

Image: Tinavi / China Daily

Medical robots are highlighted in the country's Made in China 2025 strategy, which was designed to promote high-end manufacturing.

"That was the world's first robot-assisted surgery on upper cervical vertebrae," said Tian Wei, president of Beijing Jishuitan Hospital, describing a 2015 clinical trial surgery. "Phecda is more precise than foreign products and its cost is lower."

Phecda, which is the third-generation surgery robot developed by Tinavi, is ready to be commercialized in 2017 after obtaining approval from the China Food and Drug Administration.

 Read the full article  

 Insights